The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients D. WalshS. DonnellyL. Rybicki SPEZIAL ARTICLE Pages: 175 - 179
Cachexia and anorexia: cancer's covert killer M. P. DavisE. D. Dickerson REVIEW ARTICLE Pages: 180 - 187
Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction S. MercadanteC. RipamontiL. Groff ORIGINAL ARTICLE Pages: 188 - 191
A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis T. BerghmansM. PaesmansJ.-J. Body ORIGINAL ARTICLE Pages: 192 - 197
Low-dose continuous-infusion ceftazidime monotherapy in low-risk febrile neutropenic patients E. MarshallD. B. SmithP. I. Clark ORIGINAL ARTICLE Pages: 198 - 202
A phase II study of Biotene in the treatment of postradiation xerostomia in patients with head and neck cancer P. WardeB. KrollB. Cummings ORIGINAL ARTICLE Pages: 203 - 208
Oral sequelae of chemotherapy: an important teaching opportunity for oncology health care providers and their patients G. R. SadlerL. Oberle-EdwardsW. M. Hryniuk ORIGINAL PAPER Pages: 209 - 214
Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale T. OkuyamaT. AkechiY. Uchitomi ORIGINAL ARTICLE Pages: 215 - 222
The difficult choice of chemotherapy in patients with unresectable non-small-cell lung cancer M. TamburiniG. BuccheriD. Ferrigno ORIGINAL ARTICLE Pages: 223 - 228
Prevention of cisplatin-induced delayed emesis: still unsatisfactory Italian Group for Antiemetic ResearchF. Roila SHORT COMMUNICATION Pages: 229 - 232
Antiemetic efficacy of combination therapy with granisetron plus prednisolone plus the dopamine D2 antagonist metopimazine during multiple cycles of moderately emetogenic chemotherapy in patients refractory to previous antiemetic therapy T. SigsgaardJ. HerrstedtP. Dombernowsky SHORT COMMUNICATION Pages: 233 - 237